| Literature DB >> 26718149 |
Monika Majchrzak-Gorecka1, Pawel Majewski1, Beata Grygier1, Krzysztof Murzyn2, Joanna Cichy3.
Abstract
Secretory leukocyte protease inhibitor (SLPI), a ∼12kDa nonglycosylated cationic protein, is emerging as an important regulator of innate and adaptive immunity and as a component of tissue regenerative programs. First described as an inhibitor of serine proteases such as neutrophil elastase, this protein is increasingly recognized as a molecule that benefits the host via its anti-proteolytic, anti-microbial and immunomodulatory activities. Here, we discuss the diverse functions of SLPI. Moreover, we review several novel layers of SLPI-mediated control that protect the host from excessive/dysregulated inflammation typical of infectious, allergic and autoinflammatory diseases and that support healing responses through affecting cell proliferation, differentiation and apoptosis.Entities:
Keywords: Allergy; Autoimmunity; Elastase; Inflammation; Protease
Mesh:
Substances:
Year: 2015 PMID: 26718149 DOI: 10.1016/j.cytogfr.2015.12.001
Source DB: PubMed Journal: Cytokine Growth Factor Rev ISSN: 1359-6101 Impact factor: 7.638